Intimation of Annual General Meeting to be held on 30th August, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Limited (BSE: 543594) has called its 14th AGM on Saturday, 30th August 2025 at 4:00 PM, to be held via Video Conferencing. Shareholders will vote on adopting the FY24-25 audited financial statements (FY24-25 turnover was Rs. 12,491.71 lakhs), re-appointing Mr. Nirav Soni as a director (retiring by rotation), and appointing Mr. Parin Bhavsar as an Independent Director for a 5-year term (May 2025 to May 2030). Three material related-party transactions are up for approval — each up to Rs. 100 crore — with Dhara Pharmachem Pvt Ltd, Dipan Pharmachem Pvt Ltd, and Cedac Medicorp. The company is also proposing a modest increase in authorised share capital from Rs. 25 crore to Rs. 25.5 crore (an addition of 5 lakh equity shares of Rs. 10 each). E-voting through NSDL is open from 27th to 29th August 2025, with the cut-off date set as 23rd August 2025.
For shareholders, this is largely a routine AGM notice, but the three large related-party transaction approvals (Rs. 100 crore each, well above the Rs. 12.49 crore materiality threshold based on FY25 turnover) deserve close attention for governance and arm's-length pricing. The small authorised capital hike signals room for a potential small equity issuance in the future, though no specific fundraising is announced here.